BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $344,640 | +2.9% | 48,678 | +2.4% | 0.00% | – |
| Q2 2023 | $334,809 | -15.0% | 47,558 | +0.7% | 0.00% | – |
| Q1 2023 | $393,690 | -26.8% | 47,205 | +0.8% | 0.00% | – |
| Q4 2022 | $537,506 | -58.5% | 46,821 | -54.4% | 0.00% | -100.0% |
| Q3 2022 | $1,294,000 | -38.7% | 102,666 | -48.5% | 0.00% | -50.0% |
| Q2 2022 | $2,110,000 | +251.1% | 199,409 | +439.1% | 0.00% | – |
| Q1 2022 | $601,000 | +12.5% | 36,992 | -3.9% | 0.00% | – |
| Q4 2021 | $534,000 | -30.6% | 38,501 | -28.1% | 0.00% | -100.0% |
| Q3 2021 | $769,000 | -21.6% | 53,513 | -13.8% | 0.00% | 0.0% |
| Q2 2021 | $981,000 | +32.6% | 62,084 | -14.7% | 0.00% | 0.0% |
| Q1 2021 | $740,000 | +32.9% | 72,741 | -2.7% | 0.00% | – |
| Q4 2020 | $557,000 | +194.7% | 74,780 | +36.1% | 0.00% | – |
| Q3 2020 | $189,000 | -30.0% | 54,964 | -3.1% | 0.00% | – |
| Q2 2020 | $270,000 | +309.1% | 56,698 | +72.5% | 0.00% | – |
| Q1 2020 | $66,000 | -39.4% | 32,874 | +4.5% | 0.00% | – |
| Q4 2019 | $109,000 | +14.7% | 31,465 | -5.1% | 0.00% | – |
| Q3 2019 | $95,000 | -15.9% | 33,144 | +11.4% | 0.00% | – |
| Q2 2019 | $113,000 | -55.3% | 29,753 | -4.1% | 0.00% | – |
| Q1 2019 | $253,000 | +3.7% | 31,037 | +2.8% | 0.00% | – |
| Q4 2018 | $244,000 | +79.4% | 30,180 | +69.7% | 0.00% | – |
| Q3 2018 | $136,000 | -18.1% | 17,780 | -38.6% | 0.00% | – |
| Q2 2018 | $166,000 | +26.7% | 28,960 | +5.4% | 0.00% | – |
| Q1 2018 | $131,000 | +5.6% | 27,478 | +9.1% | 0.00% | – |
| Q4 2017 | $124,000 | +96.8% | 25,193 | +109.3% | 0.00% | – |
| Q3 2017 | $63,000 | -21.2% | 12,039 | -16.3% | 0.00% | – |
| Q2 2017 | $80,000 | -27.9% | 14,375 | +8.5% | 0.00% | – |
| Q1 2017 | $111,000 | +32.1% | 13,250 | +0.3% | 0.00% | – |
| Q4 2016 | $84,000 | +44.8% | 13,205 | 0.0% | 0.00% | – |
| Q3 2016 | $58,000 | +61.1% | 13,205 | +4.5% | 0.00% | – |
| Q2 2016 | $36,000 | 0.0% | 12,639 | 0.0% | 0.00% | – |
| Q1 2016 | $36,000 | -71.7% | 12,639 | +2.6% | 0.00% | – |
| Q4 2015 | $127,000 | -9.3% | 12,317 | 0.0% | 0.00% | – |
| Q3 2015 | $140,000 | -6.7% | 12,317 | +22.3% | 0.00% | – |
| Q2 2015 | $150,000 | +0.7% | 10,070 | -38.9% | 0.00% | – |
| Q1 2015 | $149,000 | -36.6% | 16,477 | -14.9% | 0.00% | – |
| Q4 2014 | $235,000 | +29.1% | 19,356 | +4.2% | 0.00% | – |
| Q3 2014 | $182,000 | -12.5% | 18,567 | +13.9% | 0.00% | – |
| Q2 2014 | $208,000 | – | 16,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |